Back to all posts
November 18, 2026·AML Editorial

Delirium Tremens in the ICU: A Litigation Guide

delirium tremens expert witnessalcohol withdrawal malpracticeCIWA-Ar protocol litigationICU withdrawal seizure lawsuitbenzodiazepine undertreatment malpracticecritical care expert witness

A patient admitted for an unrelated surgical or medical problem — a hip fracture, pancreatitis, a routine elective procedure — has an unrecorded or minimized history of heavy daily alcohol use. Forty-eight to ninety-six hours later, nursing notes describe escalating tremor, agitation, and confusion that get written off as "ICU delirium" or postoperative pain. By the time the treating team recognizes delirium tremens for what it is, the patient has had a withdrawal seizure, aspirated, or crashed into autonomic instability that lands them on a ventilator. Attorneys evaluating these cases need a critical care or addiction medicine expert who can speak precisely to when the withdrawal history should have been identified, when a validated scoring protocol should have been initiated, and how much of the resulting injury was preventable with timely, adequately dosed treatment.

Why Delirium Tremens Is Missed or Undertreated

The single most common failure point is never asking the question. A thorough social history that specifically quantifies daily alcohol intake — not merely a checkbox for "social drinker" — is the only reliable way to identify a patient at risk before withdrawal begins. Patients frequently underreport their own use, and a record that omits any structured alcohol history in a patient who later develops severe withdrawal is a strong signal that the admission assessment fell short of accepted practice.

Early withdrawal symptoms are easy to misattribute. Tremor, tachycardia, hypertension, and anxiety in the first 6 to 24 hours after the last drink overlap heavily with postoperative pain, anxiety, or other causes of agitation common in hospitalized patients. Without a validated screening tool prompting systematic reassessment, these early signs are routinely treated with as-needed anxiolytics or simply observed, rather than triggering the structured, escalating protocol the condition requires.

The clinical course is deceptively nonlinear. Early, mild symptoms can progress within hours to withdrawal seizures (typically 12–48 hours after last use) and then to full delirium tremens — autonomic instability, hallucinations, profound confusion — which classically peaks at 48 to 96 hours but can be delayed further in patients whose last drink is uncertain. A care team anchored on an early benign-looking presentation can be caught flat-footed by a deterioration that was, in fact, predictable from the moment the alcohol history was known.

The Standard of Care: Validated Scoring and Symptom-Triggered Dosing

The accepted standard for inpatients at risk of alcohol withdrawal is systematic, scheduled reassessment using a validated instrument — most commonly the CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, revised) scale — rather than ad hoc clinical impression. CIWA-Ar scoring drives symptom-triggered benzodiazepine dosing: low scores call for observation, while escalating scores call for escalating, protocol-defined doses, reassessed on a fixed interval (often every one to two hours during active withdrawal). A chart showing sporadic or absent CIWA-Ar scoring in an at-risk patient, or scoring that was performed but not acted on when thresholds were met, is a central liability issue in this litigation.

Benzodiazepines — typically lorazepam, diazepam, or chlordiazepoxide — remain first-line therapy, and adequate dosing matters as much as the choice of agent. Patients with significant tolerance may require doses well above what a treating team unfamiliar with withdrawal protocols is comfortable giving; undertreatment out of excessive caution is a recognized and real failure mode, not merely a theoretical one. When benzodiazepine-refractory withdrawal develops, the standard of care calls for escalation — including phenobarbital or dexmedetomidine adjuncts and, for severe or refractory cases, intensive care transfer — not continued dosing at an ineffective level while the patient deteriorates.

Patients with a known or suspected alcohol use history should also receive thiamine before or concurrent with any glucose administration, to prevent precipitating Wernicke encephalopathy, and should be assessed for coexisting malnutrition and electrolyte derangement (magnesium, phosphate, potassium) that both mimic and worsen withdrawal symptoms.

Common Patterns of Negligence

Failure to obtain or document a quantified alcohol use history at admission, particularly in surgical and trauma patients where the social history is often abbreviated, leaving the care team with no basis to anticipate withdrawal.

Absent or inconsistent CIWA-Ar (or equivalent) scoring in a patient with a known or suspected alcohol history, especially across nursing shift changes, where a protocol that depends on scheduled reassessment breaks down without a standing order enforcing it.

Underdosing benzodiazepines relative to the patient's scored severity and tolerance, often driven by concern about respiratory depression or sedation that is not calibrated to the much greater risk of untreated, escalating withdrawal.

Delayed escalation when first-line therapy fails — continuing standard-dose benzodiazepines on schedule without recognizing benzodiazepine-refractory withdrawal and failing to engage critical care or add adjunctive therapy before the patient seizes or becomes hemodynamically unstable.

Inadequate monitoring after a withdrawal seizure or during peak delirium tremens risk (48–96 hours), including insufficient aspiration precautions, fall precautions, and continuous observation in a patient known to be at high risk for a second seizure or violent agitation.

Establishing Causation

Causation in delirium tremens litigation is built on the same timeline logic as other time-sensitive critical care cases: when was the alcohol history known or knowable, when did objective withdrawal signs first appear in the record, when was a validated scoring protocol initiated (if ever), and what treatment was actually given relative to the scored severity at each reassessment. The addiction medicine and critical care literature establishes clear expected timeframes for early symptoms, seizure risk, and peak delirium tremens, giving an expert a defensible framework for opining that a seizure, aspiration event, or period of prolonged ICU stay was the foreseeable consequence of a specific, identifiable gap in screening or dosing — not an unavoidable complication of the underlying disease.

Critical Documentation for Case Evaluation

Attorneys evaluating a potential delirium tremens or alcohol withdrawal malpractice case should obtain:

  • The admission history and physical, including any documented (or undocumented) alcohol use history and quantity
  • The complete nursing flowsheet and CIWA-Ar or equivalent scoring records, including frequency and any gaps
  • The medication administration record showing benzodiazepine (and any adjunct) doses and timing relative to scores
  • Vital sign trends and any documented withdrawal seizure, aspiration event, or ICU transfer with the triggering circumstances
  • Thiamine and electrolyte repletion records
  • Nursing and physician notes describing the patient's mental status trajectory across the admission

How ApexMedLaw Supports Delirium Tremens Litigation

These cases require an expert who can explain, in terms a jury can follow, why a quiet first day in the hospital can turn into a medical emergency and why a validated protocol — not clinical instinct — is the accepted way to prevent it. Our critical care and addiction medicine experts bring active clinical experience managing withdrawal in hospitalized patients to case review.

We provide detailed review of the screening, scoring, and dosing record against accepted withdrawal management protocols, causation analysis grounded in the established timeline of withdrawal progression, and credible, trial-ready testimony that makes the preventability of the outcome clear.

Contact ApexMedLaw to discuss your delirium tremens or alcohol withdrawal litigation case.


This post is for informational purposes and does not constitute legal advice. Standards vary by jurisdiction.

Frequently Asked Questions

Why is delirium tremens sometimes missed in hospitalized patients?

The most common failure is never obtaining a quantified alcohol use history at admission, so the care team has no basis to anticipate withdrawal. Early symptoms like tremor and tachycardia also overlap with pain and anxiety common in hospitalized patients, and without scheduled reassessment using a validated tool, they are often misattributed.

What is the CIWA-Ar scale and why does it matter in litigation?

The CIWA-Ar is a validated instrument used to systematically score withdrawal severity and drive symptom-triggered benzodiazepine dosing. Absent, inconsistent, or unacted-upon CIWA-Ar scoring in an at-risk patient is a central liability issue, since the standard of care calls for scheduled reassessment rather than ad hoc clinical impression.

Can underdosing benzodiazepines be a form of malpractice?

Yes. Patients with significant alcohol tolerance may require doses well above what an unfamiliar treating team is comfortable giving. Undertreatment out of excessive caution about sedation, when the patient's scored severity calls for escalation, is a recognized failure mode distinct from simply missing the diagnosis.

When does delirium tremens typically occur relative to the last drink?

Early withdrawal symptoms can begin within 6 to 24 hours, withdrawal seizures typically occur 12 to 48 hours after the last drink, and delirium tremens classically peaks at 48 to 96 hours, though timing can be delayed further when the last-use history is uncertain. This progression gives experts a defensible framework for timeline-based causation analysis.

What records are essential to evaluating a delirium tremens malpractice case?

Key records include the admission alcohol history, the complete CIWA-Ar or equivalent scoring flowsheet, the medication administration record showing benzodiazepine timing and doses, vital sign trends with any seizure or ICU transfer documentation, thiamine and electrolyte repletion records, and nursing notes describing the patient's mental status over time.

Request a Case Review

Our board-certified physician experts are available for case review, expert testimony, and independent medical examinations nationwide. Request a case review and we will match you with the right expert.